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Falciparum malaria is an important cause of acute symptomatic seizures in children admitted to hospitals in sub-Saharan Africa,
and these seizures are associated with neurological disabilities and epilepsy. However, it is difﬁcult to determine the proportion
of seizures attributable to malaria in endemic areas since a signiﬁcant proportion of asymptomatic children have malaria
parasitaemia. We studied children aged 0–13 years who had been admitted with a history of seizures to a rural Kenyan hospital
between 2002 and 2008. We examined the changes in the incidence of seizures with the reduction of malaria. Logistic regres-
sion was used to model malaria-attributable fractions for seizures (the proportion of seizures caused by malaria) to determine
if the observed decrease in acute symptomatic seizures was a measure of seizures that are attributable to malaria. The over-
all incidence of acute symptomatic seizures over the period was 651/100000/year (95% conﬁdence interval 632–670) and it
was 400/100000/year (95% conﬁdence interval 385–415) for acute complex symptomatic seizures (convulsive status epilepti-
cus, repetitive or focal) and 163/100000/year (95% conﬁdence interval 154–173) for febrile seizures. From 2002 to 2008, the
incidence of all acute symptomatic seizures decreased by 809/100000/year (69.2%) with 93.1% of this decrease in
malaria-associated seizures. The decrease in the incidence of acute complex symptomatic seizures during the period was
111/100000/year (57.2%) for convulsive status epilepticus, 440/100000/year (73.7%) for repetitive seizures and 153/
100000/year (80.5%) for focal seizures. The adjusted malaria-attributable fractions for seizures with parasitaemia were
92.9% (95% conﬁdence interval 90.4–95.1%) for all acute symptomatic seizures, 92.9% (95% conﬁdence interval
89.4–95.5%) for convulsive status epilepticus, 93.6% (95% conﬁdence interval 90.9–95.9%) for repetitive seizures and
91.8% (95% conﬁdence interval 85.6–95.5%) for focal seizures. The adjusted malaria-attributable fractions for seizures in
children above 6 months of age decreased with age. The observed decrease in all acute symptomatic seizures (809/100000/
year) was similar to the predicted decline (794/100000/year) estimated by malaria-attributable fractions at the beginning of the
study. In endemic areas, falciparum malaria is the most common cause of seizures and the risk for seizures in malaria decreases
with age. The reduction in malaria has decreased the burden of seizures that are attributable to malaria and this could lead to
reduced neurological disabilities and epilepsy in the area.
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Introduction
It is estimated that Plasmodium falciparum caused over 500 mil-
lion episodes of clinical malaria in 2002, and 70% of these were in
Africa (Snow et al., 2005). Falciparum malaria is thought to be the
most common cause of acute seizures (Waruiru et al., 1996; Idro
et al., 2008) and convulsive status epilepticus (Crawley et al.,
1996; Idro et al., 2008; Sadarangani et al., 2008) in children
admitted to hospitals in malaria endemic regions of sub-Saharan
Africa. Most of these seizures are likely to be acute symptomatic
seizures rather than febrile seizures since the infected erythrocyte
adheres to the post-capillaries vessels in the brain (Idro et al.,
2005) and over half of these seizures occur when the child is
afebrile (Waruiru et al., 1996). The seizures are often associated
with complex features (focal, repetitive or prolonged) and status
epilepticus (Waruiru et al., 1996; Idro et al., 2008; Sadarangani
et al., 2008), and these features are associated with subsequent
neurocognitive impairments (Mung’ala-Odera et al., 2004; Carter
et al., 2005; Idro et al., 2007) and the development of epilepsy
(Carter et al., 2004; Ngoungou and Preux, 2008; Birbeck et al.,
2010). Through this mechanism, falciparum malaria may be a
major cause of neurological disability in these areas.
Over the past decade, there has been a signiﬁcant reduction in
malaria transmission and admissions on the Kenyan coast
(O’Meara et al., 2008). Since malaria is an important cause of
acute seizures (Waruiru et al., 1996; Idro et al., 2008), the sig-
niﬁcant decrease in the transmission of malaria provides an oppor-
tunity to determine seizures that are attributable to malaria. We
hypothesized that the decrease in admissions with acute symp-
tomatic seizures during a period of a reduction in malaria trans-
mission would provide an appropriate measure of seizures that are
attributable to malaria. We also hypothesized that most of the
decrease in acute symptomatic seizures would occur in admissions
with a positive blood-slide for malaria or malaria-associated seiz-
ures (MAS) compared with admissions with a negative blood-slide
for malaria or non-malaria-associated seizures (non-MAS). The
observed decrease in acute symptomatic seizures between 2002
and 2008 can be compared with the proportion of seizures that
are attributable to malaria at the beginning of the study to deter-
mine if the observed decrease represents the seizures that are
attributable to malaria. However, some admissions with MAS at
the beginning of the study would not be attributable to malaria
since the prevalence of asymptomatic parasitaemia in the commu-
nity was as high as 30% during the study period (Mwangi et al.,
2005). The seizures that are attributable to malaria at the begin-
ning of the study, which predicts the decline that should follow
the reduction of malaria, can be estimated by multiplying the
malaria-attributable fractions for seizures (the proportion of seiz-
ures caused by malaria) with the incidence of MAS at the begin-
ning of the study (O’Meara et al., 2008). An observed decrease
that is similar to the predicted decline estimated by malaria-
attributable fractions for seizures would suggest that the decrease
in seizures observed is a measure of seizures that are attributable
to malaria.
The malaria-attributable fractions for seizures is a predictive
measure of the proportion of children not admitted with seizures
if malaria was completely eliminated (Smith et al., 1994; Koram
and Molyneux, 2007). Although malaria-attributable fractions for
seizures can be calculated by comparing the parasite prevalence
in seizure cases with that of other admissions that did not develop
seizures (Cole and MacMahon, 1971; Smith et al., 1994),
this method is imprecise because many children in the community
(as high as 30%) have asymptomatic malaria parasitaemia and
thus, some children presenting to hospital with MAS may have
their seizures caused by other illnesses but the parasitaemia is
co-incidental (Mwangi et al., 2005; Koram and Molyneux,
2007). Since there is no one ‘gold standard’ test to determine
‘true’ malaria (Bejon et al., 2007), malaria-attributable fractions
for seizures calculated on the basis of a positive blood-slide for
malaria alone are biased towards sensitivity but are non-speciﬁc.
Logistic regression fully uses the detailed information on parasit-
aemia distributions in both cases and comparison group and there-
fore has been suggested as a valuable alternative for modelling
malaria-attributable fractions in malaria endemic areas (Smith
et al., 1994; Mwangi et al., 2005; Bejon et al., 2007). The logistic
regression model can be modiﬁed to allow for non-continuity be-
tween negative and positive blood-slides for malaria (Smith et al.,
1994; Koram and Molyneux, 2007) and adjusts the lack of mono-
tonicity in the relationship between malaria symptoms and para-
sitaemia that is reported in some studies (Smith et al., 1994). The
model can be extended to allow for inclusion of other variables
such as age and period of study, alongside the parasitaemia when
modelling the malaria-attributable fractions for seizures (Smith
et al., 1994).
The logistic regression model uses parasitaemia from children
admitted to hospital with severe symptoms such as acute seizures
and from a comparison group to model the relation between para-
sitaemia and the symptoms of malaria (Smith et al., 1994;
Mwangi et al., 2005; Bejon et al., 2007). The parasitaemia used
in the model was assessed with optical microscopy. The logistic
regression technique models malaria-attributable fractions for vari-
ous clinical features at different thresholds of parasitaemia and
uses the modelled malaria-attributable fractions (i.e. the propor-
tion of cases within a threshold of parasitaemia) to calculate the
sensitivities (deﬁned as a measure of the proportion of seizures
with a positive blood-slide that can be positively identiﬁed as at-
tributable to malaria) and speciﬁcities (deﬁned as a measure of the
proportion of seizures with a positive blood-slide that can be
negatively identiﬁed as attributable to malaria) associated with
each threshold of parasitaemia (Smith et al., 1994; Mwangi
et al., 2005; Bejon et al., 2007). The thresholds of parasitaemia
used for deriving malaria-attributable fractions depend on the use
of the case deﬁnition (Smith et al., 1994) and previous studies
have observed that malaria-attributable fractions derived at
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sensitivities and speciﬁcities acceptable for case deﬁnitions
(Mwangi et al., 2005; Bejon et al., 2007).
We examined the changes in the incidence of admissions with
seizures over a 7-year period and used the decrease in the inci-
dence of malaria to calculate malaria-attributable fractions for seiz-
ures to determine if the observed decrease in seizures was a
measure of the childhood admissions with seizures that are attrib-
utable to malaria.
Materials and methods
Patients and procedures
We used an online database of admissions to identify all children aged
between 0 and 13 years admitted to Kiliﬁ District Hospital on the
Kenyan coast, from 2002 to 2008, with a history of seizures. We
reviewed their clinical notes to extract information on malaria status
and seizures. Kiliﬁ District Hospital is located in a regularly enumerated
demographic surveillance system area and serves a rural community of
about 100000 children (Sadarangani et al., 2008). There are two
annual peaks of malaria related to the two rainy seasons. The preva-
lence of parasitaemia in children admitted with trauma (as a measure
of background prevalence in the non-febrile community) has reduced
from 420% in 2002 to 51% in 2007 (O’Meara et al., 2008). The
decline in malaria has been attributed to the scaling-up of malaria
control interventions such as the distribution of insecticide-treated
nets, introduction of effective anti-malarial drugs and health education
(Nevill et al., 1996; Marsh et al., 1999; Amin et al., 2007; Okiro et al.,
2007). The relationship with control measures is, however, unclear and
there is evidence that transmission was falling before the interventions
were introduced (O’Meara et al., 2008). In 1998 sulphadoxine-
pyrimethamine replaced chloroquine and in 2004 artemether–lumefan-
trine was introduced (Amin et al., 2007). The introduction of
Haemophilus inﬂuenzae type B vaccine, introduced into the Kenya
Expanded Programme on Immunization in 2001, has helped reduce
the incidence of invasive haemophilus disease in this area (Cowgill
et al., 2006) and this may reduce the incidence of seizures, particularly
in young infants without parasitaemia.
Clinical management of patients
For every child admitted to the hospital, clinical and laboratory data
are entered into a standard database. The medical history included the
parental description of episodes of seizures, number and duration of
seizures. Full blood count, malaria parasitaemia, plasma glucose,
venous blood gases and blood culture were done on all children at
admission, including the comparison group comprising trauma pa-
tients. Severe malaria was deﬁned according to the WHO criteria as
a child with asexual malaria parasitaemia and either Blantyre Coma
Score 42 (i.e. cerebral malaria), respiratory distress and/or haemoglo-
bin 55g/dl (Molyneux et al., 1989; World Health Organization,
2000). Severe malaria was treated with parenteral quinine and when
the child was able to take treatment orally, it was completed with
sulphadoxine–pyrimethamine (until September 2006) or artemether–
lumefantrine thereafter.
Clinicians and nurses at the hospital provide 24-h clinical cover.
Nursing staff were trained to record details of seizures on a standard
proforma. These details included data for the time of onset and ces-
sation of seizures, anti-epileptic drugs administered and the level of
consciousness at the end of a seizure, as determined by the Blantyre
Coma Score (Molyneux et al., 1989). A standard protocol for seizure
management was used. A child with a seizure lasting 55min was
given intravenous diazepam (0.3mg/kg) and if still convulsing
10min later was given intramuscular paraldehyde (0.4mg/kg).
Intravenous phenobarbital (15mg/kg) was given for prolonged seiz-
ures (20–30min). If these seizures did not respond to these two
anti-epileptic drugs, they were termed refractory seizures and were
treated with intravenous phenytoin (18mg/kg). Children with brief
repetitive seizures (53 seizures in 1h lasting 45min) were given
phenobarbital (15mg/kg).
Case deﬁnitions for the study
The deﬁnitions for seizures were based on those of the International
League against Epilepsy (ILAE, 1989). Acute symptomatic seizures
were deﬁned as seizures in the current illness and within 1 week
prior to admission. The three main phenotypes of acute symptomatic
seizures studied were convulsive status epilepticus (deﬁned as convul-
sions lasting 430min, or intermittent convulsions without regaining
consciousness for 30min), focal seizures (deﬁned as seizures starting at
one part of the body) and repetitive symptomatic seizures (deﬁned as
more than one seizure in the same illness). Seizures that were repeti-
tive, focal or fulﬁlled the deﬁnition of convulsive status epilepticus
were termed acute complex symptomatic seizures and simple symp-
tomatic seizures as a generalized seizure without any of these features.
We further classiﬁed convulsive status epilepticus into deﬁnite, prob-
able or possible categories based on the information that was available
from the history (Table 1). Febrile seizures were deﬁned as seizures in
children aged between 1 month and 6 years who had a febrile illness
without malaria parasitaemia or evidence of bacterial meningitis
(Berkley et al., 2001) or encephalitis (cerebrospinal ﬂuid white cell
count 450/ml).
MAS were deﬁned as admissions to hospital with a history of seiz-
ures and malaria parasitaemia detected on thick and thin blood slides
stained with 10% Giemsa. Non-MAS were deﬁned as admissions to
hospital with a history of seizures and no parasitaemia detected on the
blood slides. Parasite density was quantiﬁed by count of the number of
parasites per 100 white cell counts or 500 red cell counts (if count per
100 white cell count is missing or 4100/100 white cell counts) and
multiplying these ﬁgures by whole white cell counts or red cell counts,
respectively. If whole blood cell counts data were missing, parasit-
aemia was estimated on the basis of a uniform white cell count of
8000/ml (Rogers et al., 2006).
Data management and statistical
analysis
The patient’s data were entered and tabulated in Filemaker Pro 9
Advanced (Filemaker Inc.). All analyses were computed using STATA
(version 11; Stata Corp). A probability level of 50.05 was considered
signiﬁcant.
Deriving malaria-attributable fraction for seizures
We applied logistic regression methods to model the risk of seizures as
a continuous function of malaria parasitaemia by comparing all admis-
sions with seizures (n = 4486) and a comparison group (n = 1411)
[children aged 0–13 years admitted with heterogeneous non-infectious
diagnoses such as trauma (not involving head region), burns and snake
bites]. The comparison group had no seizures on admission and the
parasitaemia seen in these children is representative of the background
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The logistic regression model used was: log(
p
1 p)= + x
z (Smith
et al., 1994), where p is the probability of admission with seizures
(where the admissions with seizures are treated as ‘positive’ and the
comparison group as ‘negative’), x is the parasite density and z is the
power function that improves the numerical stability of the maximum
likelihood estimation. The coefﬁcient () in the logistic model can be
used to calculate the risk of seizures caused by malaria for each child.
The risks of a group are averaged to estimate the proportion of the
group whose seizures are caused by ‘true’ malaria rather than another
illness with coincidental parasitaemia. The averaged risks give the posi-
tive predictive value or malaria-attributable fractions for seizures for
the group analysed (Smith et al., 1994). Sensitivity and speciﬁcity can
then be calculated using the malaria-attributable fractions for seizures
or the proportion of seizure cases within each level of parasitaemia
(Fig. 1). For this study, malaria-attributable fractions for seizures were
reported at levels of parasitaemia 52500/ml since this threshold of
parasitaemia is associated with high sensitivity and speciﬁcity for
case deﬁnitions in this area (Mwangi et al., 2005; Bejon et al., 2007).
Age and year of study were entered as covariates of parasitaemia in
the logistic regression model because the two factors are most likely to
inﬂuence the malaria-attributable fractions modelled (Smith et al.,
1994). The model was repeated in different phenotypes of acute
symptomatic seizures and various age groups. Since parasitaemia is
uncommon in children younger than 6 months of age (Idro et al.,
2008), we did not model malaria-attributable fractions for seizures
for this group. Conﬁdence intervals around the malaria-attributable
fractions for seizures were estimated by bootstrapping with 1000
iterations.
Comparison between groups
Student’s t-test was used to compare age between admissions with
MAS and those with non-MAS. All categorical data were compared
using the Pearson’s chi-squared test. The trends in mean age at ad-
mission by year were investigated with linear regression for both ad-
missions with MAS and those with non-MAS.
Calculating the incidence of seizures
The incidence analysis considered a child’s ﬁrst hospital admission with
seizures and any other subsequent admission was excluded. The inci-
dence of hospital admissions with acute symptomatic seizures was
calculated for all children who lived in the demographic surveillance
study area. The incidences were calculated using the denominator as
the annual population ﬁgures for children, which were made at the
midpoint of the years of study by ﬁtting a log-linear regression line
through the observed population counts. Additionally, the annual in-
cidence of MAS and non-MAS was calculated for all admissions with
acute symptomatic seizures. The declining trends in incidence of seiz-
ures by year were investigated using linear regression.
Estimating the decrease in the incidence of seizures
The predicted decline in acute symptomatic seizures that are attribut-
able to malaria (seizures that should decrease following the reduction
of malaria) was the incidence of MAS at 2002 (the beginning of the
study) multiplied by the malaria-attributable fractions for seizures
(O’Meara et al., 2008). The observed decrease in the incidence of
acute symptomatic seizures was the difference in the incidence be-
tween 2002 and 2008. The percentage decrease in the incidence of
seizures was the observed decrease in the incidence of seizures ex-
pressed as a percentage of the incidence at 2002. Ethical permission
Table 1 Case deﬁnitions for children admitted with acute symptomatic seizures and the number of cases admitted from the
demographic surveillance system area
Case category Criteria Number of
cases
a
Acute seizures Seizures in the current illness and within 1 week prior to admission 4486
Slide-positive seizures Seizures in children admitted with malaria parasitaemia 2762
Slide-negative seizures Seizures in children admitted without malaria parasitaemia 1724
Repetitive seizures More than one seizure in the current illness 2181
Focal seizures Convulsions localized to one part of the body 512
Deﬁnite convulsive status epilepticus Seizures lasting 430min or intermittent seizures for 430min with a Blantyre
Coma Score 42 on admission and documented by nursing or medical staff
219
Probable convulsive status epilepticus Convulsions on the way to hospital until admission 462
A Blantyre Coma Score 42 on admission and deﬁnite history of a seizure in
last 30minutes or deﬁnite history of 410 seizures in last 24h
Use of phenytoin or phenobarbital to stop uncontrolled seizures
Possible convulsive status epilepticus A Blantyre Coma Score 42 on admission and either a deﬁnite history of a
seizure in last 30min or possible history of 5–10 seizures in last 24h
266
Deﬁnite history of a seizure lasting 30min
Deﬁnite history of 45 seizures in last 24h
Non-malaria attributable seizures Sum of malaria slide-negative seizures and slide-positive seizures not attrib-
utable to malaria
1844
Malaria attributable seizures Malaria slide-positive seizures attributable to malaria 2642
Febrile seizures Seizures in children aged 1 month to 6 years who had a febrile illness without
evidence of parasitaemia or bacterial meningitis or encephalitis
1126
Total person-years The total population ﬁgures for children were made at the midpoint of the
years of study by ﬁtting a log-linear regression line through the observed
population counts.
689 053
aThe total numbers identiﬁed and summed together for each case category. Blantyre Coma Score (Molyneux et al., 1989).
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Results
General description
Over the 7-year period, a total of 34057 children aged between 0
and 13 years were admitted to Kiliﬁ District Hospital, of whom 7150
(21%) had asexual P. falciparum parasites detected on admission
and 5580 (16%) had a history of seizures (Table 2). Of the 7150
children admitted with malaria parasitaemia, 4370 (61.1%) did not
have a history of seizures during their illness leading to hospitaliza-
tion. Of the 5580 children with a history of seizures, 1007 (18%)
did not live in the study area, and were excluded from the analysis.
The analysis data set, therefore, comprised 4573 children. The data
for 9% of the 4573 children were not available from the hospital
archives and thus we could not obtain full description of the seiz-
ures. Malaria parasitaemia was detected in 140 (10%) of the 1411
comparison group and the prevalence of parasitaemia decreased
consistently between 2002 and 2008 (Table 2).
Over the surveillance period, the mean age of admissions with
MAS appeared to increase (test for trend; P = 0.001), but that of
non-MAS was unchanged (test for trend; P = 0.366) (Table 2).
Overall, children admitted with MAS were older than those
admitted with non-MAS (mean age 30.8 months versus 28.4
months; P = 0.001). The proportion of acute complex symptomatic
seizures was not different between the admissions with MAS and
those with non-MAS for convulsive status epilepticus [566/2762
(20%) versus 381/1724 (22%); P = 0.199] and focal seizures
[308/2762 (11%) versus 204/1724 (12%); P = 0.485]. However,
the proportion of recurrent seizures was different between admis-
sions with MAS and those with non-MAS [1385/2762 (48%)
versus 796/1764 (41%); P = 0.01].
Malaria-attributable fractions for
seizures
The levels of parasitaemia 52500/ml that were used for reporting
malaria-attributable fractions for all acute symptomatic seizures in
this study were associated with high sensitivities (490%) and
speciﬁcities (470%) (Fig. 1).The adjusted malaria-attributable
fractions for seizures in children admitted with acute symptomatic
seizures and parasitaemia was 92.9% [95% conﬁdence interval
(95% CI) 90.4–95.1%]. The adjusted malaria-attributable fractions
for acute complex symptomatic seizures were similar: 92.9%
(95% CI 89.4–95.5%) for convulsive status epilepticus,
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Figure 1 Sensitivity and speciﬁcity of parasite density associated with malaria-attributable fractions (MAF) for acute symptomatic seizures
in children admitted to Kiliﬁ District Hospital between 2002 and 2008. The overall MAF for seizures were reported or derived at thresholds
of parasitaemia 52500/ml since this threshold is associated with malaria illnesses in this area (Mwangi et al., 2005) and are associated with
high sensitivities and speciﬁcities that are acceptable for case deﬁnitions in this study (Smith et al., 1994). The malaria-attributable fractions
for seizures were used to determine if the observed percentage decrease in seizures during a period of a reduction in transmission of
malaria was a measure of seizures attributable to malaria.
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(95% CI 85.6–95.4% for focal seizures). The adjusted malaria-
attributable fractions for seizures in children older than 6 months
of age admitted with parasitaemia decreased with age and
were 98.3% (95% CI 96.7–99.0%) in 6–23 months old, 95.1%
(95% CI 93.4–96.8%) in 24–59 months old and 93.5% (95% CI
92.1–95.1%) in 59–156 months old children.
The burden of acute seizures
The overall incidence of acute symptomatic seizures was
651/100000/year (95% CI 632–670) and it was 400/100000/
year (95% CI 385–415) for acute complex symptomatic seizures.
The incidence of MAS was 401/100000/year (95% CI 368–416)
and that of non-MAS was 250/100000/year (95% CI 237–262).
The overall incidence of acute complex symptomatic seizures was
137/100000/year (95% CI 129–147) for convulsive status epilep-
ticus, 316/100000/year (95% CI 304–330) for repetitive seizures
and 74/100000/year (95% CI 68–81) for focal seizures. The
annual incidence of acute complex MAS is shown in Table 2.
The overall incidence of admissions with an overlap of the three
phenotypes of seizures (convulsive status epilepticus, repetitive and
focal) was 10/100000/year (95% CI 8–13) (Fig. 2). The greatest
overlap was between repetitive seizures and convulsive status epi-
lepticus [74/100000/year (95% CI 58–70)]. The incidence of ad-
missions with an overlap between focal seizures and repetitive
seizures was 28/100000/year (95% CI 24–32) while that for focal
seizures and convulsive status epilepticus was 5/100000/year (95%
CI 5–9). The overall incidence of admissions with simple generalized
seizures was 258/100000/year (95% CI 246–270).
The overall incidence of admissions with febrile seizures was
163/100000/year (95% CI 154–173). The incidence of febrile
convulsive status epilepticus was 12/100000/year (95% CI
9–15) and that for febrile focal seizures and febrile repetitive seiz-
ures was 7/100000/year (95% CI 5–9) and 52/100000/year
(95% CI 47–58), respectively. The incidence of simple generalized
febrile seizures was 70/100000/year (95% CI 64–77).
The incidence of febrile seizures with an overlap of all the
three phenotypes of acute complex symptomatic seizures was
2/100000/year (95% CI 1–3). The overlap of febrile seizures with
complex features was highest between repetitive seizures and
Table 2 Secular trends in paediatric admissions to Kiliﬁ District Hospital between 2002 and 2008 and the incidence of acute
symptomatic seizures by malaria association
Admission proﬁles 2002 2003 2004 2005 2006 2007 2008 Total
Number of admissions from within and
outside the DSS
4851 5539 5056 4751 5016 4496 4348 34057
Number of admissions with history of
seizures from within and outside DSS
1310 1521 964 430 433 530 392 5580
Number of MAS from the DSS
a 734 1028 392 230 207 79 110 2780
Number of admissions with non-MAS
from the DSS
a
271 246 326 200 219 249 282 1793
Mean age (standard error) in months for
MAS from the DSS
30.2 (0.9) 29.9 (0.7) 29.7 (1.0) 31.8 (1.3) 35.1 (1.6) 40.1 (2.7) 32.9 (2.0)
Mean age (standard error) in months for
non-MAS from the DSS
29.3 (1.6) 30.1 (1.6) 29.4 (1.7) 26.5 (1.9) 25.2 (1.7) 27.1 (1.9) 30.0 (1.6)
Parasite prevalence (%) in the compari-
son group for this study
16 46 33 24 18 6 6
Person-years 85827 89592 97099 100303 103492 105289 107451 689053
Previous study’s incidence of
slide-positive admissions per 1000
(O’Meara et al., 2008)
b
17.2 18.4 11.3 7.3 5.8 3.4 –
Previous study’s parasite prevalence (%)
in trauma patients (O’Meara et al.,
2008)
b
19 24 13 11 7 1 –
Annual incidence of admissions with acute symptomatic seizures/100000/year
All MAS 855 1147 404 229 200 75 102
All non-MAS 316 275 316 197 206 200 260
CSE MAS 139 180 117 61 52 26 28
CSE non-MAS 54 40 89 47 53 49 55
Repetitive MAS 432 569 192 119 101 39 50
Repetitive non-MAS 164 132 159 75 96 89 107
Focal MAS 136 101 38 25 25 5 7
Focal non-MAS 54 26 30 29 30 13 30
a Admission numbers as contained in the online admission database, of which 69 and 18 children did not show any evidence of seizures on review of clinical for the MAS
and non-MAS groups, respectively.
b These ﬁgures were part of another analysis (O0Meara et al., 2008). The annual population ﬁgures for children were made at the midpoint of the years of study by ﬁtting a
log-linear regression line through the observed population counts.
CSE = Convulsive status epilepticus; DSS = the demographic surveillance system.
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incidence of febrile seizures with both focal and convulsive status
epilepticus features was 1/100000/year (95% CI 0.5–2) while
that for those with both focal and repetitive features was 6/
100000/year (95% CI 4–8).
Changes in the incidence of seizures
Declining trends
From 2002 to 2008, the incidence of all admissions with acute
symptomatic seizures demonstrated a signiﬁcant declining trend
(P50.001). Similarly, the three types of acute complex symptom-
atic seizures showed a declining trend during the period [convul-
sive status epilepticus (test for declining trend; P50.001),
repetitive seizures (test for declining trend; P50.001) and focal
seizures (test for declining trend; P50.001)]. The decrease for the
incidence of MAS was greater than that of non-MAS for all types
of acute symptomatic seizures (Fig. 3).
Observed decrease
From 2002 to 2008, all acute symptomatic seizures decreased by
809/100000/year (69.2%) with 93.1% of the decrease occurring
in MAS (Table 3). During the same period, convulsive status
epilepticus decreased by 111/100000/year (57.2%) and all
(100%) of the decrease was seen in MAS. From 2002 to 2008,
repetitive seizures decreased by 440/100000/year (73.7%) and
86.8% of this decrease occurred in MAS. During the study
period, focal seizures decreased by 153/100000/year (80.5%)
with 84.3% of this decline in MAS.
Predicted decline
The predicted decline estimated by multiplying the incidence of
MAS at the beginning of the study by malaria-attributable frac-
tions for seizures indicated that acute symptomatic seizures would
decrease by 794/100000/year following the reduction of malaria
(Table 3). During the same period, acute complex symptomatic
seizures were predicted to decline by 129/100000/year for con-
vulsive status epilepticus, 404/100000/year for repetitive seizures
and 125/100000/year for focal seizures.
The observed decrease (809/100000/year) in all acute
symptomatic seizures was similar to the predicted decline
(794/100000/year) that was estimated using malaria-attributable
fractions for seizures at the beginning of the study (Table 3).
Additionally, the observed decrease in the three types of acute symp-
tomatic seizures were similar to the predicted decline estimated using
malaria-attributable fractions for seizures at the beginning of the
509 (18.5%) 
74 per 100 000/year 
326 (11.8%) 
47 per 100 000/year  
1408 (51.1%) 
204 per 100 000/year 
71 (2.6%) 
10 per 100 000/year  
193 (7.0%) 
28 per 100 000/year 
41 (1.5%) 
6 per 100 000/year  
207 (7.5%) 
30 per 100 000/year 
Convulsive status
epilepticus
Focal
seizures
Repetitive seizures 
Figure 2 The proportion of acute complex symptomatic seizures documented during the study period. There was an overlap between
the three seizure phenotypes. The greatest overlap was between convulsive status epilepticus and repetitive seizures, followed by
repetitive seizures and focal seizures; focal seizures, convulsive status epilepticus and repetitive seizures; and focal seizures and convulsive
status epilepticus. The absolute estimates are expressed as a percentage of the total acute complex symptomatic seizures (n = 2755).
The corresponding incidences per 100000 per year are also provided.
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the predicted decline calculated using malaria-attributable fractions
for seizures for all types of acute symptomatic seizures except
convulsive status epilepticus.
Discussion
We found that the overall incidence of acute symptomatic seizures was
651/100000/year (95% CI 632–670) and it was 400/100000/year
(95% CI 385–415) and 163/100000/year (95% CI 154–173) for
acute complex symptomatic seizures and febrile seizures, respect-
ively. The adjusted malaria-attributable fractions for acute symp-
tomatic seizures in all admissions with parasitaemia were relatively
high and decreased with age in children older than 6 months of
age. From 2002 to 2008, all acute symptomatic seizures decreased
by 809/100000/year (69.2%) with 93.1% of this decrease
occurring in MAS. The observed decrease (809/100000/year) in
all acute symptomatic seizures was similar to the predicted decline
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Figure 3 The changes in the incidence of admissions with acute symptomatic seizures between 2002 and 2008. All acute symptomatic
seizures decreased during the period and most of the decrease occurred in malaria-associated seizures (MAS) compared with non-MAS
(P50.001). Similarly, most of the decrease observed in the three types of acute complex symptomatic seizures occurred in MAS
compared with non-MAS.
Table 3 The malaria-attributable fractions for seizures, the predicted and the observed decrease in the incidence of seizures
and the proportion of the observed decrease that occurred in malaria-associated seizures
Type of seizures Adjusted malaria-
attributable
fractions for seizures
(95% CI)
Predicted decline
in seizures using
malaria-attributable
fractions/100000/year
Observed decrease
in seizures/100000/year
(percentage decrease)
Proportion of the observed
decrease that occurred
in MAS
All acute symptomatic seizures 92.9% (90.4–95.1%) 794 809 (69.2%) 753/100000/year (93.1%)
Convulsive status epilepticus 92.9% (89.4–95.5%) 129 111 (57.2%) 111/100000/year (100%)
Repetitive seizures 93.6% (90.9–95.9%) 404 440 (73.7%) 382/100000/year (86.8%)
Focal seizures 91.8% (85.6–95.4%) 125 153 (80.5%) 129/100000/year (84.3%)
The predicted decline in the incidence of seizures was the incidence of MAS in 2002 (the beginning of the study) multiplied by the malaria-attributable fractions for seizures.
Annual incidences of seizures are provided in Table 2. The observed decrease in the incidence of seizures was the difference in the incidence between 2002 and 2008 (the
end of study). Percentage decrease was the decrease in the incidence expressed as a percentage of the incidence at 2002.
1526 | Brain 2011: 134; 1519–1528 S. M. Kariuki et al.(794/100000/year) that was estimated using malaria-attributable
fractions for seizures.
Malaria-attributable fractions for
seizures
We modelled malaria-attributable fractions for seizures to deter-
mine the proportion of seizures that would decrease following the
reduction of malaria. We calculated malaria-attributable fractions
for seizures with logistic regression since the high prevalence of
asymptomatic parasitaemia in the community (Mwangi et al.,
2005) can result in some seizures caused by other illnesses with
coincidental parasitaemia being incorrectly classiﬁed as attributable
to malaria if other methods were used (Smith et al., 1994). The
adjusted malaria-attributable fractions for all acute symptomatic
seizures were derived at parasitaemia levels 52500/ml since this
threshold was shown to be associated with malaria illnesses in
previous studies in this area (Mwangi et al., 2005; Bejon et al.,
2007) and is associated with high sensitivities and speciﬁcities in
this study. Malaria-attributable fractions for seizures were high
and similar among the three acute complex symptomatic seizures
with only repetitive seizures particularly attributable to malaria.
We found high malaria-attributable fractions for seizures in chil-
dren 46 months and these attributable fractions decreased with
age, which may reﬂect the increasing immunity and tolerance to
malaria as children grow older. This ﬁnding, however, is predictive
of what would normally be expected of the risk of seizures in
malaria with age when the transmission intensity of malaria is
stable. The mean age of children with MAS appeared to increase
over the study period compared with that of children with
non-MAS and supports the hypothesis that the pathogenesis of
seizures in malaria is related to intrinsic factors of host age as well
as the transmission intensity and levels of parasitaemia. A decrease
in transmission of malaria impairs the development of immunity
(Snow et al., 1997) and thus older children are admitted with
severe complications such as cerebral malaria (O’Meara et al.,
2008), which is strongly associated with seizures.
Changes in the incidence of seizures
Most of the observed decrease in the incidence of seizures
occurred in MAS compared with non-MAS and supports the hy-
pothesis that the decrease observed in seizures is associated with
the reduction of malaria (O’Meara et al., 2008). The observed
decrease in acute symptomatic seizures was similar to the pre-
dicted decline that was estimated by malaria-attributable fractions
for seizures in 2002 and supports the hypothesis that the decrease
in seizures during a period of a reduction in malaria transmission is
an approximate measure of seizures that are attributable to mal-
aria. Nevertheless, the observed decrease was larger than the pre-
dicted decline by 15/100000/year, which could be attributable to
other factors other than the reduction in malaria.
The observed decrease that was in excess of the predicted de-
cline calculated using malaria-attributable fractions for seizures is
probably caused by the improvement in health services rather than
the malaria control interventions that led to the reduction of mal-
aria. Such improvements include more widespread use of
antimicrobials, the improvement in the treatment of seizures in
the peripheral health facilities [although anti-epileptic drugs are
not readily available in rural areas (Ahmad et al., 2006)] and the
reduction in haemophilus meningitis following the introduction of
H. inﬂuenzae type B vaccine (Cowgill et al., 2006). The ﬁnding
that the decrease caused by the improvement in health services
did not occur in convulsive status epilepticus could suggest that
another non-malarial cause of status epilepticus, such as epilepsy
(Sadarangani et al., 2008) was still high during the study period.
Since acute complex symptomatic seizures are important in the
pathogenesis of severe malaria (Crawley et al., 1996) and are
associated with neurocognitive impairments and development of
epilepsy (Carter et al., 2005; Idro et al., 2007; Sadarangani et al.,
2008), the decrease in the incidence of these seizures could lead
to a reduction in the incidence and prevalence of neurological
disabilities and mortality in this area.
Limitations
These incidence rates are conservative because almost all of the
seizures detected were convulsive seizures and non-convulsive
seizures may have been missed. Furthermore, we could not ascer-
tain the proportion of patients whose seizures had been treated
with anti-epileptics drugs at the peripheral prior referral since this
may have reduced the number of referrals or admissions with
seizures. However, very few patients, if any, will have received
prior treatment for seizures before admission because anti-epileptic
drugs such as diazepam and phenobarbital are not readily avail-
able in the community (Ahmad et al., 2006). Additionally, some
seizure cases may have been missed because traditional healers
only refer the severely sick children to Kiliﬁ District Hospital
(Waruiru et al., 1996), hospital user fee charges may reduce hos-
pital use (Chuma et al., 2009) and some children with short seiz-
ures would not be referred to hospital (Sadarangani et al., 2008).
The malaria-attributable fractions for seizures calculated from a
single blood-slide does not account for the parasitaemia that
may have been undetected by the less sensitive optical microscopy
(Ochola et al., 2006). Furthermore, the density of parasitaemia
can ﬂuctuate signiﬁcantly within hours and therefore use of para-
sitaemia from a single blood ﬁlm complicates the modelling
(Koram and Molyneux, 2007).
Conclusion
The high malaria-attributable fractions for seizures modelled in this
study conﬁrms that falciparum malaria is the most common cause
of acute symptomatic seizures in children admitted to hospital with
parasitaemia in a malaria endemic area and that the risk for seiz-
ures decreases with age. The observed decrease in the incidence
of seizures was similar to the predicted decline that was estimated
using the modelled malaria-attributable fractions for seizures and
suggests that the decrease observed is an approximate measure of
the childhood admissions with seizures that are attributable to
malaria. The observed decrease in seizures could lead to reduced
neurological disabilities and epilepsy associated with malaria in this
area.
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